Propanc Biopharma completes $500K first tranche of share buyback

August 5, 2026 8:30 AM

Propanc Biopharma, Inc. (Nasdaq: PPCB) announced it has completed the first tranche of its $5.0 million share repurchase program, purchasing ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found